The deal spread will be driven by RKLB stock price volatility and regulatory progress over the ~12-month timeline. Monitor Iridium's proxy filing (Form S-4) for the fairness opinion detail and any competing bids — the no-shop clause (from the merger agreement) constrains Iridium but does not prohibit a superior proposal. Alignment risk: if RKLB stock declines below the $67.50 collar floor, the fixed 0.4 exchange ratio provides downside protection for Iridium shareholders.
Price Chart
Executive Summary
Iridium Communications filed a Rule 425 investor/analyst email confirming the definitive agreement to be acquired by Rocket Lab for $54.00 per share ($27.00 cash plus Rocket Lab stock via a collar-based exchange ratio), implying an $8.0 billion enterprise value (~24% premium to last close). This is a routine communication with no new material financial terms or deal structure changes — it reiterates the mid-2027 expected close and customary conditions (stockholder vote, regulatory approvals). The cross-filing context shows this is one of several identical 425 filings on the same day, reinforcing an active but very early-stage deal process.
Key Financial Metrics
Key Facts
- Iridium agreed to be acquired by Rocket Lab at $54.00 per share (half cash, half stock), implying ~$8.0B enterprise value
- Shareholders receive $27.00 cash plus a variable exchange ratio of Rocket Lab stock based on a 10-day VWAP collar: 0.4 if RKLB ≤ $67.50, 0.24 if ≥ $112.50, or $27.00 / VWAP in between
- Transaction expected to close mid-2027, pending Iridium stockholder approval and regulatory clearances
Financial Impact
All-cash portion of $27.00/share plus stock consideration; enterprise value ~$8.0 billion; ~24% premium to last close
Risk Factors
- Regulatory approval risk (FCC, CFIUS, antitrust) — satellite/communications sector faces heightened national security scrutiny
- Rocket Lab stock volatility directly impacts the stock consideration value; the collar protects Iridium holders only partially
- Mid-2027 timeline is unusually long; risk of deal fatigue or intervening material adverse change
- Potential competing bid could emerge given Iridium's strategic satellite assets and current premium level
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001104659-26-078928 |
| Document: 0001104659-26-078928-index-headers.html | 0001104659-26-078928 |
| Document: 0001104659-26-078928-index.html | 0001104659-26-078928 |
| Document: 0001104659-26-078928.txt | 0001104659-26-078928 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 425 | $47.09 $48.65 | ▲ +3.31% | ▲ +1.20% | $49.14 (+4.35%) |
Sep 15, 2026 17d ago | 8-K | $47.09 $48.65 | ▲ +3.31% | ▲ +1.20% | $49.14 (+4.35%) |
Sep 3, 2026 28d ago | 425 | $47.21 $46.18 | ▼ −2.18% | ▼ −0.97% | $49.14 (+4.09%) |
Aug 19, 2026 6w ago | Insider Cluster | $48.45 $47.64 | ▼ −1.67% | ▼ −2.79% | $49.14 (+1.42%) |
Aug 19, 2026 6w ago | Insider Cluster | $48.71 $47.20 | ▲ +3.10% | ▲ +2.71% | $49.14 (−0.88%) |
Aug 10, 2026 7w ago | 8-K | $49.38 $49.03 | ▼ −0.71% | ▼ −0.31% | $49.14 (−0.49%) |
Aug 6, 2026 8w ago | 425 | $49.93 $50.20 | ▲ +0.54% | ▲ +0.14% | $49.14 (−1.58%) |
Jul 22, 2026 10w ago | 8-K | $46.86 $44.36 | ▼ −5.33% | ▼ −2.93% | $49.14 (+4.87%) |
Jul 9, 2026 12w ago | Press Release | $50.06 $46.61 | ▲ +6.89% | ▲ +6.33% | $49.14 (+1.84%) |
Jul 6, 2026 12w ago | 425 | $51.09 $48.86 | ▼ −4.36% | ▼ −4.92% | $49.14 (−3.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access